Eupraxia Pharmaceuticals (EPRX)

• Market cap: $459M
• 1 day: 15.1%
• 5 days: 0.33%
• 1 month: 18.1%
• 3 months: 48.93%
• 6 months: 68.59%
• Year to date: 19.82%
• 1 year: 199.34%
• 5 years: 207.46%
• 10 years: 207.46%
• Sector: Healthcare
• Industry: Biotechnology

About: Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Employees: 33